SPONSOR
PT. Prodia Stem Cell Indonesia
Total Trials
2
Recruiting
2
Phases
EARLY_Phase 1, Phase 1, Phase 2
PT. Prodia Stem Cell Indonesia is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Carpal Tunnel Syndrome (CTS), Diabetic Nephropathy Type 2.
The trial portfolio spans EARLY_Phase 1, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — PT. Prodia Stem Cell Indonesia
How many clinical trials has PT. Prodia Stem Cell Indonesia sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by PT. Prodia Stem Cell Indonesia, of which 2 are actively recruiting participants. These trials cover conditions including Carpal Tunnel Syndrome (CTS), Diabetic Nephropathy Type 2. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does PT. Prodia Stem Cell Indonesia research focus on?
PT. Prodia Stem Cell Indonesia clinical trials span Carpal Tunnel Syndrome (CTS), Diabetic Nephropathy Type 2. The research pipeline includes EARLY_Phase 1, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a PT. Prodia Stem Cell Indonesia clinical trial?
To participate in a PT. Prodia Stem Cell Indonesia trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all PT. Prodia Stem Cell Indonesia trials with current recruitment status updated daily.
Clinical Trials by PT. Prodia Stem Cell Indonesia
NCT07723313 EARLY_Phase 1
Recruiting
Effectiveness of Amniotic Membrane Combined With Secretome as an Adjunct to Carpal Tunnel Release Surgery: Evaluation Using the Boston Carpal Tunnel Questionnaire and Electromyography
Carpal Tunnel Syndrome (CTS)
NCT07396155 Phase 1, Phase 2
Recruiting
Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy in Diabetic Nephropathy Patients: A Clinical Trial
Diabetic Nephropathy Type 2
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology